DEBORAH GRIFFIN: Open Payments
NPI 1922174309 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,054 in 69 payments from 35 companies in 2025. Trend: 2023 $2,670 · 2024 $1,955 · 2025 $2,054
Food & beverage: $1,785Education: $269
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 2 | $194 |
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| SOBI, INC | 4 | $158 |
| Astellas Pharma US Inc | 5 | $148 |
| ABBVIE INC. | 2 | $144 |
| Amgen Inc. | 1 | $138 |
| Janssen Biotech, Inc. | 5 | $103 |
| Eisai Inc. | 4 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $83 |
| Alexion Pharmaceuticals, Inc. | 4 | $73 |
Products named: ERLEADA, Vonjo, EVENITY, EPKINLY, Lenvima, ENHERTU, ULTOMIRIS, Xospata.
Industry payments across MI — which companies pay providers there.
